Review of the AAGT intensive care committee clinical consensus on the management of patients with rhabdomyolysis
https://doi.org/10.51922/2616-633X.2022.6.1.1563
Abstract
Rhabdomyolysis is a condition characterized by the primary (mechanical) or the secondary (metabolic) damage to skeletal muscles, resulting in cell death and massive release of potentially toxic substances into the general circulation. Alertness to this complex pathological condition is very low among primary care physicians. Most often, traumatologists-orthopedists and resuscitators deal with the clinical picture of rhabdomyolysis. However, an in-depth analysis of literature data on the etiopathogenesis of this process implies a wide range of specialties, who need knowledge of the clinical picture of the development of rhabdomyolysis as well as of therapeutic specifics and prevention to manage this specific contingent patient. At the end of 2021, the clinical consensus of the intensive care committee of the American Association for the Surgery of Trauma (AAST) took place, which resulted in the formulation of recommendations for the management of patients with rhabdomyolysis. The document reviews and compiles knowledge of the causes of muscle fiber breakdown, diagnosis, treatment, and outcomes of acute rhabdomyolysis in critically ill patients.
About the Authors
A. Titova
Belarusian State Medical University
Belarus
Belarus
Minsk
M. Terenin
6th City Clinical Hospital
Belarus
Belarus
Minsk
I. Dovgalevich
Belarusian State Medical University
Belarus
Belarus
Minsk
S. Motuz
6th City Clinical Hospital
Belarus
Belarus
Minsk
A. Mishchenko
Chausskaya Central District Hospital
Belarus
Belarus
Chausy, Mogilev region
References
1. Bosch X., Poch E., Grau J.M. Rhabdomyolysis and acute kidney injury. N Engl J Med, 2009, vol. 361, pp. 62-72. doi: 10.1056/NEJMra0801327.
2. Chavez L.O., Leon M., Einav S., Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care, 2016, vol. 20, pp. 135. doi: 10.1186/s13054-016-1314-5.
3. Allison R.C., Bedsole D.L. The other medical causes of rhabdomyolysis. Am J Med Sci, 2003, vol. 326, pp. 79-88. doi: 10.1097/00000441-200308000-00005.
4. Brown C.V.R., Rhee P., Chan L., Evans K., Demetriades D., Velmahos G.C. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma, 2004, vol. 56, pp. 1191-1196. doi: 10.1097/01.ta.0000130761.78627.10.
5. Oda J., Tanaka H., Yoshioka T., Iwai A., Yamamura H., Ishikawa K., Matsuoka T., Kuwagata Y., Hiraide A., Shimazu T., Sugimoto H. Analysis of 372 patients with crush syndrome caused by the Hanshin-Awaji earthquake. J Trauma, 1997, vol. 42, pp. 470-476. doi: 10.1097/00005373-199703000-00015.
6. Brown C.V.R., Rhee P., Evans K., Demetriades D., Velmahos G., Velhamos G. Rhabdomyolysis after penetrating trauma. Am Surg, 2004, vol. 70, pp. 890-892.
7. Odeh M. The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med, 1991, vol. 324, pp. 1417-1422. doi: 10.1056/NEJM199105163242007.
8. Gabow P.A., Kaehny W.D., Kelleher S.P. The spectrum of rhabdomyolysis. Medicine, 1982, vol. 61, pp. 141-152.
9. Sinert R., Kohl L., Rainone T., Scalea T. Exercise-Induced rhabdomyolysis. Ann Emerg Med, 1994, vol. 23, pp. 1301-1306. doi: 10.1016/s0196-0644(94)70356-6.
10. Petejova N., Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care, 2014, vol. 18, pp. 224. doi: 10.1186/cc13897.
11. Hodel C. Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol Lett, 2002, vol. 128, pp. 159-168. doi: 10.1016/s0378-4274(02)00010-3.
12. Guzé B.H., Baxter L.R. Neuroleptic malignant syndrome. N Engl J Med, 1985, vol. 313, pp. 163-166. doi: 10.1056/NEJM198507183130306.
13. Stahl K., Rastelli E., Schoser B. A systematic review on the definition of rhabdomyolysis. J Neurol, 2020, vol. 267, pp. 877-882. doi: 10.1007/s00415-019-09185-4.
14. Cabral B.M.I., Edding S.N., Portocarrero J.P., Lerma E.V. Rhabdomyolysis. Dis Mon, 2020, vol. 66, pp. 101015. doi: 10.1016/j.disamonth.2020.101015.
15. Lim A.K. Abnormal liver function tests associated with severe rhabdomyolysis. World J Gastroenterol, 2020, vol. 26, pp. 1020-1028. doi: 10.3748/wjg.v26.i10.1020.
16. Lim A.K.H., Arumugananthan C., Lau Hing Yim C., Jellie L.J., Wong E.W.W., Junckerstorff R.K. A cross-sectional study of the relationship between serum creatine kinase and liver biochemistry in patients with rhabdomyolysis. J Clin Med, 2019, vol. 9, pp. 81. doi: 10.3390/jcm9010081.
17. Cote D.R., Fuentes E., Elsayes A.H., Ross J.J., Quraishi S.A. A “crush” course on rhabdomyolysis: risk stratification and clinical management update for the perioperative clinician. J Anesth, 2020, vol. 34, pp. 585-98. doi: 10.1007/s00540-020-02792-w.
18. Sauret J.M., Marinides G., Wang G.K. Rhabdomyolysis. Am Fam Physician, 2002, vol. 65, pp. 907-912.
19. Amyot S.L., Leblanc M., Thibeault Y., Geadah D., Cardinal J. Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med, 1999, vol. 25, pp. 1169-1172. doi: 10.1007/s001340051031.
20. McMahon G.M., Zeng X., Waikar S.S. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med, 2013, vol. 173, pp. 1821-1828. doi: 10.1001/jamainternmed.2013.9774.
21. Rodríguez E., Soler M.J., Rap O., Barrios C., Orfila M.A., Pascual J. Risk factors for acute kidney injury in severe rhabdomyolysis. PLoS One, 2013, vol. 8, pp. e82992. doi: 10.1371/journal.pone.0082992.
22. Baeza-Trinidad R., Brea-Hernando A., Morera-Rodriguez S., Brito-Diaz Y., Sanchez-Hernandez S., El Bikri L., Ramalle-Gomara E., Garcia-Alvarez J.L. Creatinine as predictor value of mortality and acute kidney injury in rhabdomyolysis. Intern Med J, 2015, vol. 45, pp. 1173-1178. doi: 10.1111/imj.12815.
23. Chen C.-Y., Lin Y.-R., Zhao L.-L., Yang W.-C., Chang Y.-J., Wu H.-P. Clinical factors in predicting acute renal failure caused by rhabdomyolysis in the ED. Am J Emerg Med, 2013, vol. 31, pp. 1062-1066. doi: 10.1016/j.ajem.2013.03.047.
24. Shapiro M.L., Baldea A., Luchette F.A. Rhabdomyolysis in the intensive care unit. J Intensive Care Med, 2012, vol. 27, pp. 335-342. doi: 10.1177/0885066611402150.
25. Zimmerman J.L., Shen M.C. Rhabdomyolysis. Chest, 2013, vol. 144, pp. 1058-1065. doi: 10.1378/chest.12-2016.
26. Scharman E.J., Troutman W.G. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother, 2013, vol. 47, pp. 90-105. doi: 10.1345/aph.1R215.
27. Homsi E., Barreiro M.F., Orlando J.M., Higa E.M. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail, 1997, vol. 19, pp. 283-288. doi: 10.3109/08860229709026290.
28. Kellum J.A., Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care, 2013, vol. 17, pp. 204. doi: 10.1186/cc11454.
29. Sanders P.W., Booker B.B. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest, 1992, vol. 89, pp. 630-639. doi: 10.1172/JCI115629.
30. Shintani S., Shiigai T., Tsukagoshi H. Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment. Eur Neurol, 1991, vol. 31, pp. 396-398. doi: 10.1159/000116702.
31. Zeng X., Zhang L., Wu T., Fu P. Continuous renal replacement therapy (CRRT) for rhabdomyolysis. Cochrane Database Syst Rev, 2014, vol. 6, pp. CD008566. doi: 10.1002/14651858.CD008566.pub2.
32. Wakabayashi Y., Kikuno T., Ohwada T., Kikawada R. Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure. Intensive Care Med, 1994, vol. 20, pp. 109-112. doi: 10.1007/BF01707664.
33. Peltonen S., Ahlström A., Kylävainio V., Honkanen E., Pettilä V. The effect of combining intermittent hemodiafiltration with forced alkaline diuresis on plasma myoglobin in rhabdomyolysis. Acta Anaesthesiol Scand, 2007, vol. 51, pp. 553-558. doi: 10.1111/j.1399-6576.2007.01289.x.
34. Kodadek L., Carmichael S.P., Seshadri A., Pathak A., Hoth J. Rhabdomyolysis: an American Association for the Surgery of Trauma critical care committee clinical consensus document. Trauma Surg Acute Care Open, 2022, vol. 7, pp. e000836. doi: 10.1136/tsaco-2021-000836.
Review
For citations:
Titova A., Terenin M., Dovgalevich I., Motuz S., Mishchenko A. Review of the AAGT intensive care committee clinical consensus on the management of patients with rhabdomyolysis. Emergency Cardiology and Cardiovascular Risks journal. 2022;6(1):1563-1571. (In Russ.) https://doi.org/10.51922/2616-633X.2022.6.1.1563
Views:
6
Email this article 